KYTX

Kyverna Therapeutics, Inc. KYTX

Individual Beneficiary

Name of reporting person Citizenship or organization Sole voting power Shared voting power Sole dispositive power Shared dispositive power Amount beneficially owned Percent of class Accepted date
JPMORGAN CHASE & Delaware 2037226 0 2380021 0 2380021 5.5 % 10/10/2024

Senat trading

Bureau Date de la transaction Date de réception Type Amount Commentaire

Senat Divulgation

Représentant Date de la transaction Date de divulgation Type Amount District